ArticleClinical and experimental immunology2020

Recombinant Mycobacterium bovis BCG is a promising platform to develop vaccines against Trypansoma cruzi infection.

I Bontempi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.